财务数据和关键指标变化 - 第四季度收入为2.42亿美元,同比增长73%,其中剔除汇率和收购影响的核心增长为2% [29] - 毛利率为50.9%,同比增加450个基点,主要由于3M食品安全业务的并购以及价格成本的正面影响 [36] - 调整后EBITDA为6300万美元,同比增长97%,调整后EBITDA利润率为26.1%,同比增加320个基点 [37][38] - 调整后净利润为3000万美元,每股收益为0.14美元,上年同期分别为2200万美元和0.21美元 [38][39] - 截至第四季度,公司总债务为9亿美元,其中67%为固定利率,现金头寸为2.46亿美元,净负债率为2.8倍 [40] 各条业务线数据和关键指标变化 - 食品安全业务收入为1.69亿美元,同比增长151%,核心增长3.9% [30] - 其中培养基及其他类别高单位数核心增长,食品质量和营养分析产品表现强劲 [30] - 细菌和一般卫生类别中,Soleris微生物检测产品增长强劲,但部分产品线转移至3M业务 [31] - 自然毒素和过敏原类别略有核心收入下降,主要由于停止了针对国际乳品市场的药物检测试剂盒业务 [32] - 动物安全业务收入为7300万美元,核心增长温和,其中兽医器械和一次性用品增长最强劲 [33] - 生物安全组合中,清洁剂和杀虫剂增长强劲,但杀虫剂销量下降 [33] - 基因组学业务全球收入中单位数核心增长,主要得益于国际牛肉市场和宠物检测的良好表现 [34] 各个市场数据和关键指标变化 - 3M食品安全业务在第三季度有显著改善,核心收入增长近8%,其中Petrifilm产品线低双位数增长,过去订单积压有所减少 [35] - 公司正在与3M的过渡制造合作伙伴合作,生产水平有所提高,并相信已经进入了更加稳定的运营节奏 [13][14] 公司战略和发展方向及行业竞争 - 公司正在加快整合3M食品安全业务的其他三大产品线,预计到第三季度末将全部完成整合,除Petrifilm外 [20] - 公司还计划在第三季度底前完全退出与3M的过渡服务协议,包括后台职能和分销服务 [20] - 公司正在持续创新,如推出Petrifilm Plate Reader Advanced,利用人工智能提高检测速度和准确性 [16][17][18][19] - 公司正在进一步拓展Reveal系列产品,推出了针对鱼类和干燥动物蛋白的组胺定量检测,以及谷物中DON和黄曲霉毒素的定量检测 [21][22] - 公司的基因组学业务也在不断创新,如推出了用于奶牛杂交牛的Igenity BeefxDairy产品 [23][24][25] - 公司正在持续扩大产品组合,以更好地保护食品供应链的质量 [26] 管理层对经营环境和未来前景的评论 - 尽管当前市场环境有所疲软,但公司相信食品安全和动物安全两大业务的历史韧性将继续 [49] - 公司在整合工作的同时,也保持了业务增长的关注,2024财年将是公司发展的关键一年 [50] - 到本财年末,除Petrifilm外,其他3M产品线将全部整合到Neogen的设施中,公司将专注于提高生产效率 [50] - 公司还将在第三季度底前完全独立于3M的后台职能和分销服务,同样将专注于提高效率 [50] - 公司将继续优先发展产品创新,以差异化自己在市场上的地位,并计划充分利用新老团队成员的技能和专长 [51][52] 问答环节重要的提问和回答 问题1 **Tim Daley 提问** 关于Petrifilm业务的改善,具体是由于消化积压订单、过渡制造安排改善还是核心增长? [57][58] **Dave Naemura 回答** Petrifilm业务的改善主要是由于从积压订单转向订单减少,这反映了更好的市场走势。公司将继续与3M合作,管理这种关系,但相信已经度过了最大的问题 [59][60] 问题2 **Brandon Vazquez 提问** 2024财年收入指引中,对动物安全和食品安全业务的预期分别是什么? [71][72] **Dave Naemura 回答** 两个业务分别预计中单位数增长,食品安全业务增速略高于动物安全 [72] 问题3 **David Westenberg 提问** 到2024和2025财年,公司自主控制的产品线占比分别是多少? [91][92] **John Adent 回答** 除Petrifilm外,其他3M产品线将在第三季度末全部整合到Neogen,同时公司也将在该时点退出与3M的过渡服务协议,包括后台职能和分销 [91][92]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended February 28, 2023. or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-17988 Neogen Corporation (Exact name of registrant as specified in its charter) Michigan 38-2367843 (State or other jurisdict ...

Neogen Corporation (NASDAQ:NEOG) Q3 2023 Earnings Conference Call March 30, 2023 8:00 AM ET Company Participants Bill Waelke - Head, IR John Adent - President and CEO Dave Naemura - CFO Conference Call Participants Brandon Vazquez - William Blair David Westenberg - Piper Sandler Operator Operator Welcome to the Neogen Third Quarter Fiscal Year 2023 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] Please note today's event is being recorded. I'd now like to tu ...

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |-------|-------|-------|-------|-------|-------|-------|-------|----------------|---------------------------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Third | | Fiscal Year 2023 -Quarter | | | | | | | | | | | Results | | | | | | | | | | | | March 30, 2023 | | | Disclaimer Forward-Looking Statements This presentation includes "forward-looking statements" as that term is defined in Secti ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2022. or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-17988 Neogen Corporation (Exact name of registrant as specified in its charter) Michigan 38-2367843 (State or other jurisdict ...

Neogen Corporation (NASDAQ:NEOG) Q2 2023 Results Conference Call January 5, 2023 8:00 AM ET Company Participants Bill Waelke - Investor Relations John Adent - President and Chief Executive Officer Steve Quinlan - Retiring Chief Financial Officer Dave Naemura - Current Chief Financial Officer Conference Call Participants Brandon Vazquez - William Blair David Westenberg - Piper Sandler Operator Good morning, and welcome to the Neogen Corporation Second Quarter Fiscal Year 2023 Earnings Call. All participants ...

Neogen Corporation (NASDAQ:NEOG) Q1 2023 Earnings Conference Call September 27, 2022 11:00 AM ET Company Participants John Adent - President and CEO Steve Quinlan - Chief Financial Officer Conference Call Participants David Westenberg - Piper Sandler Brandon Vazquez - William Blair Operator Good day and welcome to the Neogen Corporation First Quarter Fiscal Year 2023 Earnings Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to John Adent, ...

Neogen Corporation (NASDAQ:NEOG) Q4 2022 Earnings Conference Call July 26, 2022 11:00 AM ET Company Participants John Adent - President and CEO Steve Quinlan - Chief Financial Officer Conference Call Participants Andrew Brackmann - William Blair Operator Good morning. And welcome to the Neogen Corporation Fourth Quarter and Full Year 2022 Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today???s presentation, there will be an opportunity to ask questions. [Oper ...

Neogen Corporation. (NASDAQ:NEOG) Q3 2021 Earnings Conference Call March 24, 2022 11:00 AM ET Company Participants John Adent - President and Chief Executive Officer Steve Quinlan - Chief Financial Officer Conference Call Participants Christine Rains - William Blair David Westenberg - Piper Sandler Operator Good day and welcome to the Neogen Corporation Third Quarter Fiscal Year 2022 Earnings Conference Call. [Operator Instructions]. Please note, this event is being recorded. I would now like to turn the co ...

Neogen Corporation (NASDAQ:NEOG) Q2 2022 Earnings Conference Call December 21, 2021 11:00 AM ET Company Participants John Adent - Chief Executive Officer Steve Quinlan - Chief Financial Officer Conference Call Participants Christine Rains - William Blair David Westenberg - Piper Sandler Operator Good day and welcome to the Neogen Fiscal Year 2022 Second Quarter Earnings call. All participants will be in listen-only mode. [Operator Instructions] Please note, this event is being recorded. I would now like to ...